Ország: Ausztrália
Nyelv: angol
Forrás: Department of Health (Therapeutic Goods Administration)
Vinorelbine tartrate
Fresenius Kabi Australia Pty Limited
Medicine Registered
CMI for Vinorelbine Kabi March 2011 VinCMI230311 VINORELBINE KABI Vinorelbine (as tartrate) CONSUMER MEDICINE INFORMATION _ _ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about VINORELBINE KABI. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you being given VINORELBINE KABI against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT VINORELBINE KABI IS USED FOR VINORELBINE KABI is used to treat advanced breast cancer and non-small cell lung cancers. VINORELBINE KABI belongs to a class of medicines called antineoplastic or cytotoxic medicines. This medicine works by stopping cancer cells from growing and multiplying. You may have been given another medicine to treat your lung or breast cancer. However, your doctor has now decided to treat you with VINORELBINE KABI instead. VINORELBINE KABI may be used alone or in combination with other medicines to treat cancer Ask your doctor if you have any questions about why VINORELBINE KABI has been prescribed for you. Your doctor m Olvassa el a teljes dokumentumot
VinPI230311 PRODUCT INFORMATION NAME OF MEDICINE Vinorelbine Kabi Concentrated Injection The name of the medicine is vinorelbine as vinorelbine tartrate (vinorelbine bitartrate). CHEMICAL NAME: 3',4'-didehydro-4'-deoxy-C'-norvincaleukoblastine (R-(R*,R*)-2,3 dihydroxybutanedioate (1:2)(salt)). MOLECULAR FORMULA: C 45 H 54 N 4 O 8 . 2(C 4 H 6 O 6 ) MOLECULAR WEIGHT: 1079.12 CAS REGISTRY NUMBER: 125317-39-7 DESCRIPTION Vinorelbine tartrate is a semi-synthetic vinca alkaloid with anti-tumour activity. It is a concentrated solution administered after dilution via intravenous infusion. It is a clear, white to yellow or light brown amorphous powder. Dissolved in water vinorelbine is a clear, colourless to pale yellow solution. Each vial contains vinorelbine tartrate equivalent to 10 mg (1mL vial) or 50 mg (5mL vial) vinorelbine in Water for Injections. VINORELBINE KABI contains no preservatives or other additives are present. The aqueous solution is sterile and nonpyrogenic. The aqueous solubility is > 1000 mg/mL in distilled water. The pH of VINORELBINE KABI injection is approximately 3.5. PHARMACOLOGY Vinorelbine is a cytostatic antineoplastic drug. It is a semi-synthetic member of the vinca alkaloid family that interferes with microtubule assembly. The vinca alkaloids are structurally similar compounds comprised of two multiringed units, vindoline and catharanthine. Unlike other vinca alkaloids, the catharanthine unit is the site of structural modification for vinorelbine. The antitumor activity of vinorelbine is thought to be due primarily to inhib Olvassa el a teljes dokumentumot